Literature DB >> 15655740

Fluoroquinolone-resistant pneumococci: maybe resistance isn't futile?

Donald E Low.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15655740     DOI: 10.1086/426822

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


× No keyword cloud information.
  6 in total

1.  Fitness costs of fluoroquinolone resistance in Streptococcus pneumoniae.

Authors:  Daniel E Rozen; Lesley McGee; Bruce R Levin; Keith P Klugman
Journal:  Antimicrob Agents Chemother       Date:  2006-11-20       Impact factor: 5.191

2.  Susceptibility of Streptococcus pneumoniae to fluoroquinolones in Canada.

Authors:  Samir N Patel; Allison McGeer; Roberto Melano; Gregory J Tyrrell; Karen Green; Dylan R Pillai; Donald E Low
Journal:  Antimicrob Agents Chemother       Date:  2011-05-31       Impact factor: 5.191

Review 3.  Resistance surveillance studies: a multifaceted problem--the fluoroquinolone example.

Authors:  A Dalhoff
Journal:  Infection       Date:  2012-03-30       Impact factor: 3.553

4.  Pediatric fluoroquinolone prescription in South Korea before and after a regulatory intervention: A nationwide study, 2007-2015.

Authors:  Seung Yeon Song; Joo Hee Shin; Su Yeong Hyeon; Donguk Kim; Won Ku Kang; Soo-Han Choi; Yae-Jean Kim; Eun Young Kim
Journal:  PLoS One       Date:  2017-05-17       Impact factor: 3.240

5.  Global fluoroquinolone resistance epidemiology and implictions for clinical use.

Authors:  Axel Dalhoff
Journal:  Interdiscip Perspect Infect Dis       Date:  2012-10-14

6.  Risk factors and clinical significance of invasive infections caused by levofloxacin-resistant Streptococcus pneumoniae.

Authors:  M C Isea-Peña; J C Sanz-Moreno; J Esteban; R Fernández-Roblas; M L Fernández-Guerrero
Journal:  Infection       Date:  2013-05-25       Impact factor: 3.553

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.